Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cluster-randomised, Open-label Trial to Compare the Impact of Combined Mass Vaccine and Drug Administrations, Mass Drug Administration, Mass Vaccinations, or no Intervention on Plasmodium Falciparum Malaria Transmission

NCT06068530 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT06068530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06068530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cluster-randomised, Open-label Trial to Compare the Impact of Combined Mass Vaccine and Drug Administrations, Mass Drug Administration, Mass Vaccinations, or no Intervention on Plasmodium Falciparum Malaria Transmission
Lead sponsor
University of Oxford
Phase
Phase 4
Overall status
Recruiting
Start date
February 15, 2025
Completion date
February 1, 2028
Enrollment
10,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

plasmodium falciparum malaria